RE:PLWH have twofold risk of liver fibrosis Do you recall how big the subgroup of Hiv patiemnts will be included in the Nash trial?I think there could be a chance that FDA could allow a Label Extension for Nash HIV patients when the DSMB carries oiut an interim review .....Am I dreaming?